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METHOD AND MATERIALS
 
We conducted a retrospective cohort study of 85 baseline 
abdominal CT scans from patients with predicted severe acute 
pancreatitis included in an international multicenter study on 
the use of antibiotic prophylaxis in severe acute pancreatitis.  
All CT scans were reviewed and the following SCOREs 
calculated: Balthazar SCORE, CT severity index and the newly 
developed EPIC SCORE. The EPIC SCORE is based on the 
presence of a. pleural effusion; b. peri-splenic, peri-hepatic, 
interloop and/or pelvic ascites; c. retroperitoneal inflammation 
and d. mesenteric inflammation, on a scale from 0 to 7.  
The performance of the radiological SCOREs to predict outcome 
(defined as mortality, need for surgery and the development of 
organ dysfunction (MODSSCORE of 3 or higher at any moment 
during the course of disease) was evaluated by constructing 
ROC curves and calculating the area under the curve (AUROC) 
for the outcome parameters. Data are reported as mean 
(standard deviation), a p-value of 0.05 or less was considered 
statistically significant. 
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RESULTS
 
Mean age of the patients was 53 years (17,8), 58 of them 
(69%) were male. APACHE II SCORE, Ranson SCORE and 
modified Glasgow SCORE was 11.4 (6.87), 4.1 (2.04) and 3.8 
(1.95) respectively.  
Pancreatic necrosis was documented in 74 patients (10 patients 
did not receive IV contrast CT scan), and was estimated <30% 
in 27, 30-50% in 34 and >50% in 13. 
Ten patients (12%) needed surgery for complications of severe 
acute pancreatitis, and 10 patients eventually died because of 
progression of pancreatitis or (peri-)pancreatic infection. 
The AUROC curve for predicting mortality was 0.61 for the EPIC 
SCORE, 0.63 for the CT severity index, and 0.55 for the 
Balthazar SCORE. The AUROC curve for predicting the need for 
surgery was 0.73 for the EPIC SCORE, 0.68 for the CT severity 
index, and 0.55 for the Balthazar SCORE. The AUROC curve for 
predicting the development of organ dysfunction was 0.65 for 
the EPIC SCORE, 0.54 for the CT severity index, and 0.51 for 
the Balthazar SCORE. 
  
  
 CONCLUSION
 
The EPIC SCORE performed at least comparable to the 
established CT Severity Index in a cohort of patients with 
severe acute pancreatitis; the Balthazar performed only poor in 
this analysis. 
  
 
CLINICAL RELEVANCE/APPLICATION
 
Uncomplicated CT scoring system for predicting the outcome of 
acute pancreatitis 
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